Live from ASCO 2025: Boehringer Ingelheim on unmet needs and oncology innovation

Boehringer Ingelheim’s data presented at ASCO 2025 reflected the company’s broad pipeline and growing body of evidence supporting innovative therapies for various cancers. In a pharmaphorum podcast recorded onsite at the Congress, web editor Nicole Raleigh spoke with Itziar Canamasas, global head of oncology at Boehringer Ingelheim, for a discussion of the unmet needs in oncology and some of the specifics of the company’s data presentations. The conversation also touches upon highlights from this year’s annual meeting and hopes for transformation of the oncological field in the future. Watch this and other interviews from ASCO 2025 here.